Trial Profile
Comparative Effectiveness of Belimumab Use among SLE Patients in a Commercially Insured US Population: 2010-2014
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Belimumab (Primary) ; Immunosuppressants
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 29 Aug 2016 New trial record